A Study of BAY 43-9006 in Combination With Bicalutamide in Patients With Chemo-Naïve Hormone Refractory Prostate Cancer
- Conditions
- First Posted Date
- 2007-02-01
- Last Posted Date
- 2010-08-05
- Lead Sponsor
- British Columbia Cancer Agency
- Target Recruit Count
- 39
- Registration Number
- NCT00430235
- Locations
- 🇨🇦
BC Cancer Agency - Vancouver Centre, Vancouver, British Columbia, Canada
Intensity Modulated Versus Interstitial - Radiation Therapy
- Conditions
- Interventions
- First Posted Date
- 2006-12-05
- Last Posted Date
- 2018-07-13
- Lead Sponsor
- British Columbia Cancer Agency
- Target Recruit Count
- 50
- Registration Number
- NCT00407875
- Locations
- 🇨🇦
BC Cancer Agency, Vancouver, British Columbia, Canada
Study of Patupilone in Prostate Cancer Patients Who Progress After Hormone Therapy and Docetaxel Chemotherapy
- Conditions
- First Posted Date
- 2006-12-04
- Last Posted Date
- 2010-11-05
- Lead Sponsor
- British Columbia Cancer Agency
- Target Recruit Count
- 73
- Registration Number
- NCT00407251
- Locations
- 🇨🇦
Princess Margaret Hospital, Toronto, Ontario, Canada
🇨🇦Tom Baker Cancer Centre, Calgary, Alberta, Canada
🇨🇦BC Cancer Agency - Vancouver Centre, Vancouver, British Columbia, Canada
Chemoradiation for Locally Advanced and Low Rectal Cancers: Avastin-Capecitabine-Oxaliplatin-Radiation REctal Cancer Trial
- Conditions
- First Posted Date
- 2006-10-12
- Last Posted Date
- 2010-11-25
- Lead Sponsor
- British Columbia Cancer Agency
- Target Recruit Count
- 43
- Registration Number
- NCT00386828
- Locations
- 🇨🇦
CancerCare Manitoba, Winnipeg, Manitoba, Canada
🇨🇦Tom Baker Cancer Centre, Calgary, Alberta, Canada
🇨🇦BC Cancer Agency - Vancouver Centre, Vancouver, British Columbia, Canada
Phase-II Study of SU011248 (Sunitinib)in Male Patients With Relapsed or Cisplatin-Refractory Germ Cell Cancer
- Conditions
- First Posted Date
- 2006-09-04
- Last Posted Date
- 2009-07-08
- Lead Sponsor
- British Columbia Cancer Agency
- Target Recruit Count
- 33
- Registration Number
- NCT00371553
- Locations
- 🇨🇦
Cancer Care Manitoba, Winnipeg, Manitoba, Canada
🇨🇦London Regional Cancer Centre, London, Ontario, Canada
🇨🇦QEII Health Science Center, Halifax, Nova Scotia, Canada
Tailoring Treatment for B Cell Non-hodgkin's Lymphoma Based on PET Scan Results Mid Treatment
- Conditions
- Interventions
- First Posted Date
- 2006-05-11
- Last Posted Date
- 2021-07-22
- Lead Sponsor
- British Columbia Cancer Agency
- Target Recruit Count
- 150
- Registration Number
- NCT00324467
- Locations
- 🇨🇦
BC Cancer Agency, Vancouver, British Columbia, Canada
Acupuncture in Palliative Cancer Care
- Conditions
- Interventions
- First Posted Date
- 2006-03-14
- Last Posted Date
- 2010-10-20
- Lead Sponsor
- British Columbia Cancer Agency
- Target Recruit Count
- 20
- Registration Number
- NCT00302185
- Locations
- 🇨🇦
BC Cancer Agency - Vancouver Island Centre, Victoria, British Columbia, Canada
The Use of Silver Leaf Dressing in the Prevention of Radiotherapy Induced Skin Reactions
- Conditions
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2007-06-27
- Lead Sponsor
- British Columbia Cancer Agency
- Target Recruit Count
- 100
- Registration Number
- NCT00207324
- Locations
- 🇨🇦
BC Cancer Agency, Vancouver, British Columbia, Canada
18F-fluorodeoxyglucose (18F-FDG) Positron Emission Tomography in Oncology
- Conditions
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2019-01-10
- Lead Sponsor
- British Columbia Cancer Agency
- Target Recruit Count
- 39242
- Registration Number
- NCT00207298
- Locations
- 🇨🇦
BCCA, Vancouver Centre, Vancouver, British Columbia, Canada
Budesonide in Treating Former and Current Smokers With Bronchial Dysplasia
- Conditions
- First Posted Date
- 2004-02-25
- Last Posted Date
- 2008-07-24
- Lead Sponsor
- British Columbia Cancer Agency
- Registration Number
- NCT00005880
- Locations
- 🇨🇦
British Columbia Cancer Agency, Vancouver, British Columbia, Canada